| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | CELGENE CORP | 3,564,298 | 412,514,000 | 11.18% | ||
| 2 | INCYTE CORP | 3,740,406 | 389,788,000 | 10.57% | ||
| 3 | IONIS PHARMACEUTICAL | 5,929,426 | 341,238,000 | 9.25% | ||
| 4 | GILEAD SCIENCES INC | 2,715,596 | 317,942,000 | 8.62% | ||
| 5 | RADIUS HEALTH INC | 3,922,140 | 265,529,000 | 7.20% | ||
| 6 | AGIOS PHARMACEUTICALS INC | 1,989,921 | 221,160,000 | 6.00% | ||
| 7 | VERTEX PHARMACEUTICALS INC | 1,334,445 | 164,777,000 | 4.47% | ||
| 8 | NEUROCRINE BIOSCIENCES INC | 3,221,552 | 153,861,000 | 4.17% | ||
| 9 | MEDIVATION INC | 1,290,556 | 147,381,000 | 4.00% | ||
| 10 | ALEXION PHARMACEUTICALS | 777,428 | 140,536,000 | 3.81% | ||
| 11 | HALOZYME THERAPEUTICS INC | 6,077,168 | 137,222,000 | 3.72% | ||
| 12 | Receptos Inc | 665,272 | 126,435,000 | 3.43% | ||
| 13 | ALNYLAM PHARMACEUTICALS INC | 965,499 | 115,734,000 | 3.14% | ||
| 14 | REGENERON PHARMACEUTICALS | 198,000 | 101,006,000 | 2.74% | ||
| 15 | NOVAVAX INC | 8,180,000 | 91,125,000 | 2.47% | ||
| 16 | TETRAPHASE PHARMACEUTICALS I | 1,507,114 | 71,497,000 | 1.94% | ||
| 17 | ALDER BIOPHARMACEUTICALS INC | 1,155,150 | 61,188,000 | 1.66% | ||
| 18 | PUMA BIOTECHNOLOGY INC | 521,991 | 60,942,000 | 1.65% | ||
| 19 | CEMPRA INC | 1,766,900 | 60,711,000 | 1.65% | ||
| 20 | PTC THERAPEUTICS INC | 1,252,912 | 60,303,000 | 1.63% | ||
| 21 | Clovis Oncology, Inc. | 618,188 | 54,326,000 | 1.47% | ||
| 22 | TESARO INC | 904,582 | 53,180,000 | 1.44% | ||
| 23 | INTERCEPT PHARMACEUTICALS IN | 180,719 | 43,622,000 | 1.18% | ||
| 24 | INFINITY PHARMACEUTICALS INC | 2,700,737 | 29,573,000 | 0.80% | ||
| 25 | JUNO THERAPEUTICS INC | 450,000 | 23,999,000 | 0.65% | ||
| 26 | KITE PHARMA INC | 350,000 | 21,340,000 | 0.58% | ||
| 27 | ACHILLION PHARMACEUTICALS IN | 1,279,340 | 11,335,000 | 0.31% | ||
| 28 | INNOVIVA INC COM | 331,594 | 5,992,000 | 0.16% | ||
| 29 | THERAVANCE BIOPHARMA INC | 359,190 | 4,677,000 | 0.13% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0000950123-15-008623, filed 2015.08.12).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
